Association between genetic variations in tumor necrosis factor receptor genes and survival of patients with T-cell lymphoma

The prognosis of T-cell lymphoma (TCL) has been shown to be associated with the clinical characteristics of patients. However, there is little knowledge of whether genetic variations also affect the prognosis of TCL. This study investigated the associations between single nucleotide polymorphisms(SNPs) in tumor necrosis factor receptor superfamily(TNFRSF) genes and the survival of patients with TCL. A total of 38 tag SNPs in 18 TNFRSF genes were genotyped using Sequenom platform in 150 patients with TCL. Kaplan-Meier survival estimates were plotted and significance was assessed using log-rank tests. Cox proportional hazard models were used to analyze each of these 38 SNPs with adjustment for covariates that might influence patient survival, including sex and international prognostic Index score. Hazard ratios (HRs) and their 95% confidence intervals(CIs) were calculated. Among the 38 SNPs tested, 3 were significantly associated with the survival of patients with TCL. These SNPs were located at LTβR (rs3759333C>T) and TNFRSF17(rs2017662C>T and rs2071336C>T). The 5-year survival rates were significantly different among patients carrying different genotypes and the HRs for death between the different genotypes ranged from 0.45 to 2.46. These findings suggest that the SNPs in TNFRSF genes might be important determinants for the survival of TCL patients.

Functional XPF polymorphisms associated with lung cancersusceptibility in a Chinese population

Variation of individuals’DNA repair capacity has been linked to cancer susceptibility.The xeroderma pigmentsum group F(XPF)plays a pivotal role in nucleotide-excision repair(NER)pathway.This study was to examine the functional significance of XPF promoter polymorphisms and their association with lung cancer risk.The function of XPF promoter polymorphisms was tested by a set of biochemical assays,and their effects on lung cancer risk were determined by a case-control analysis of 988 patients with lung cancer and 986 controls.The XPF–673T allele showed a significantly higher transcriptional activity as compared with the–673C allele.The–673TT genotype was associated with a decreased risk of lung cancer compared with the CC genotype(adjusted OR=0.62,95%CI=0.42–0.91;P=0.015)and this effect was more significant among males(adjusted OR=0.55,95%CI=0.35–0.86;P=0.009),elder subjects(adjusted OR=0.51,95%CI=0.30–0.86;P=0.012),and light smokers(adjusted OR=0.35,95%CI=0.14–0.88;P=0.026).Thesefindings suggest that functional polymorphisms influencing DNA repair capa-city may confer susceptibility to lung cancer.